Skip to main content

Immaculada Raurell Saborit

Institutions of which they are part

Postdoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Immaculada Raurell Saborit

Institutions of which they are part

Postdoctoral researcher
Liver Diseases
Vall Hebron Institut de Recerca

Projects

Caracterización de las claves fisiopatológicas y fenotipos de la enfermedad del hígado graso metabólica con ingesta moderada de alcohol para identificar nuevas terapias (ReLiveR).

IP: Meritxell Ventura Cots
Collaborators: Immaculada Raurell Saborit, Juan Manuel Pericas Pulido, Laura Puente Ramo, Ares Aurora Villagrasa Vilella, Maria de la Serra Cusidó Sabidó, Maria Martínez Gómez, Alba Maria Jiménez Masip
Funding agency: Instituto de Salud Carlos III
Funding: 183920
Reference: PI22/01770
Duration: 01/01/2023 - 31/12/2026

Malalties hepàtiques

IP: Joan Genescà Ferrer
Collaborators: Beatriz Minguez Rosique, Sergi Colomer Castell, Elena Vargas Accarino, Immaculada Raurell Saborit, Lluís Viladomiu Catà, Lluis Castells Fusté, Maria del Mar Riveiro Barciela, Maria Buti Ferret, Malalties hepàtiques, Judit Romero Vico, Josep Quer Sivila, Malalties hepàtiques, Juan Manuel Pericas Pulido, Malalties hepàtiques, Malalties hepàtiques, Laura Puente Ramo, Isabel Campos Varela, Malalties hepàtiques, Juan Ignacio Esteban Mur, Ester Palacio Gutierrez, Susana Anton Calvo, Monica Higuera Urbano, Meritxell Ventura Cots, Ares Aurora Villagrasa Vilella, Emma Bigas Alsina, Carolina Campos Martinez, Macarena Simon-Talero Horga, David Tabernero Caellas, Mònica Pons Delgado, Marcella Salzano
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00462
Duration: 01/01/2022 - 30/06/2025

OPTIMIZACIÓN DE NUEVOS TRATAMIENTOS EN LA ENFERMEDAD HEPÁTICA CRÓNICA-NASH

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Mònica Pons Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 268620
Reference: PI21/00691
Duration: 01/01/2022 - 30/06/2026

De la sencillez en el diagnóstico (no masivo) y seguimiento de la enfermedad hepática crónica avanzada a los complejos mecanismos terapéuticos de las estatinas en modelos animales.

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Ares Aurora Villagrasa Vilella, Mònica Pons Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 196020
Reference: PI18/00947
Duration: 01/01/2019 - 30/06/2023

Related news

The results, published in The Lancet and Nature Medicine, provide new evidence to improve the diagnosis of metabolic dysfunction-associated steatotic liver disease and reduce the need for liver biopsies.

The CHANCE study analyzes the outcomes of nearly 1,000 patients at 63 liver transplant centers and identifies which patients with the most severe forms of the disease may benefit from transplantation.

The grants support projects led by Drs. María José Buzón, María Buti, Elena Élez, and Maria Vieito.

Related professionals

Tomàs Pumarola Suñé

Tomàs Pumarola Suñé

Main researcher
Microbiology
Read more
Mercè Beltran Vilagrasa

Mercè Beltran Vilagrasa

Cap d'Unitat
Internal Strategy Directorate
Read more
Marc Ribó Jacobi

Marc Ribó Jacobi

Main researcher
Stroke research
Read more
Luis Enrique Lara Moctezuma

Luis Enrique Lara Moctezuma

Kidney Physiopathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.